Arestocaine Hcl

   
Google
 
Web NewDrugInformation.com

Arestocaine Hcl


Drug - Arestocaine Hcl
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mepivacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 3%
The potency of the active ingredient(s), Mepivacaine Hydrochloride. May repeat for multiple part products.

Applicant - SOLVAY
The firm name holding legal responsibility for Arestocaine Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 084777
The FDA assigned number to Arestocaine Hcl. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Arestocaine Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 18, 1982
The date Arestocaine Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Arestocaine Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Arestocaine Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Solvay Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of Arestocaine Hcl.

Arestocaine Hcl